Hepsera



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Hepatitis B 51.9%
Hepatic Cirrhosis 14.9%
Product Used For Unknown Indication 8.2%
Drug Use For Unknown Indication 5.2%
Chronic Hepatitis B 3.9%
Gastritis 1.9%
Hiv Infection 1.8%
Hypertension 1.8%
Osteoporosis 1.5%
Amyotrophic Lateral Sclerosis 1.4%
Constipation 1.2%
Chronic Hepatitis 1.1%
Hepatitis B Virus 1.0%
Hepatitis B Virus Test 0.8%
Gastric Ulcer 0.7%
Insomnia 0.6%
Immunosuppression 0.5%
Antiviral Treatment 0.5%
Depression 0.5%
Hypothyroidism 0.5%
Hepatic Neoplasm Malignant 11.6%
Osteomalacia 11.3%
Renal Impairment 9.8%
Renal Tubular Disorder 8.0%
Renal Failure 7.0%
Viral Load Increased 6.7%
Viral Mutation Identified 4.3%
Tubulointerstitial Nephritis 4.0%
Thrombocytopenia 3.7%
Alanine Aminotransferase Increased 3.4%
Fanconi Syndrome Acquired 3.4%
Hepatitis B 3.4%
Weight Decreased 3.4%
Drug Ineffective 3.1%
Hepatitis 3.1%
Liver Disorder 3.1%
Hypophosphataemia 2.8%
Platelet Count Decreased 2.8%
Rash 2.8%
Renal Disorder 2.8%
Secondary
Hepatitis B 39.5%
Hepatic Cirrhosis 18.7%
Drug Use For Unknown Indication 11.4%
Product Used For Unknown Indication 6.6%
Hiv Infection 4.8%
Chronic Hepatitis B 3.3%
Osteoporosis 2.8%
Gastritis 2.8%
Hypertension 2.2%
Amyotrophic Lateral Sclerosis 1.3%
Constipation 1.3%
Ascites 1.1%
Hepatitis B Virus Test 0.8%
Gastric Ulcer 0.6%
Gastroenteritis 0.6%
Renal Failure 0.6%
Antifungal Prophylaxis 0.4%
Atrial Fibrillation 0.4%
Liver Disorder 0.4%
Pain 0.4%
Hepatic Neoplasm Malignant 14.6%
Renal Failure 9.4%
Renal Tubular Disorder 7.5%
Osteomalacia 7.0%
Renal Impairment 6.6%
Tubulointerstitial Nephritis 5.6%
Weight Decreased 5.6%
Viral Load Increased 4.7%
Blood Creatinine Increased 4.2%
Fanconi Syndrome 4.2%
Urticaria 3.8%
Vomiting 3.8%
Renal Disorder 3.3%
Hepatic Failure 2.8%
Liver Disorder 2.8%
Multiple Fractures 2.8%
No Therapeutic Response 2.8%
Pneumocystis Jiroveci Pneumonia 2.8%
Spinal Compression Fracture 2.8%
Stevens-johnson Syndrome 2.8%
Concomitant
Hepatitis B 21.3%
Product Used For Unknown Indication 12.0%
Hepatic Cirrhosis 11.4%
Hepatic Neoplasm Malignant 10.6%
Drug Use For Unknown Indication 6.7%
Diabetes Mellitus 6.1%
Prophylaxis 3.9%
Hypertension 3.6%
Liver Transplant 3.6%
Aplastic Anaemia 3.4%
Constipation 2.5%
Hiv Infection 2.2%
B-cell Lymphoma 1.9%
Gastrointestinal Disorder 1.9%
Hepatitis C 1.9%
Gastritis 1.7%
Iron Overload 1.6%
Hyperammonaemia 1.4%
Immunosuppression 1.4%
Dyspepsia 1.2%
Rash 10.5%
Renal Impairment 9.5%
Weight Decreased 8.4%
Hepatic Function Abnormal 6.3%
Vomiting 6.3%
Osteoporosis 5.3%
Palmar-plantar Erythrodysaesthesia Syndrome 5.3%
Viral Load Increased 5.3%
Hepatic Failure 4.2%
Hepatitis B 4.2%
Platelet Count Decreased 4.2%
Sepsis 4.2%
Syncope 4.2%
Chemical Peritonitis 3.2%
Hepatic Neoplasm Malignant 3.2%
Hepatitis B Dna Increased 3.2%
Loss Of Consciousness 3.2%
Oesophageal Varices Haemorrhage 3.2%
Pancytopenia 3.2%
Rectal Cancer 3.2%